EUS- and US- Guided Biopsy for Pancreatic Lesion

N/ANot Yet RecruitingNCT07138976

Tian'an Jiang2,517 enrolled

Overview

Endoscopic ultrasound (EUS) and ultrasound (US) are the two primary imaging modalities used to guide pancreatic needle biopsy. This study aimed to compare the diagnostic performance and complications associated with EUS- and US-guided pancreatic biopsies.

Study Type

OBSERVATIONAL

Enrollment

2,517

Conditions

Pancreatic Cancer

Interventions

sampling tissueOTHER

EUS- and US- guided pancreatic biopsy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Between January 2017 and December 2023, 2663 consecutive patients with focal pancreatic disease underwent 2729 procedures for pancreatic tissue acquisition from focal pancreatic lesions at seven university teaching hospitals in China. Exclusion Criteria: * Patients were excluded from the study if they had less than 12 months of follow-up, were lost to follow-up, had incomplete follow-up data, or underwent intraoperative biopsy or fluid aspiration.

Outcomes

Primary Outcomes

diagnostic inaccuracy

Time frame: 1-year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.